menu
    • menu

    Company profile for BenevolentAI

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BenevolentAI is creating and applying AI technologies to transform the way medicines are discovered, developed, tested and brought to market. The Company has developed the Benevolent Platform™ - a leading computational and experimental discovery platform used by BenevolentAI scientists to find new ways to treat disease and personalise drugs to patients. The Benevolent Platform™ focuses on four key areas of drug discovery ...
    BenevolentAI is creating and applying AI technologies to transform the way medicines are discovered, developed, tested and brought to market. The Company has developed the Benevolent Platform™ - a leading computational and experimental discovery platform used by BenevolentAI scientists to find new ways to treat disease and personalise drugs to patients. The Benevolent Platform™ focuses on four key areas of drug discovery and development: Knowledge and Reasoning, Target Identification, Molecular Design and Precision Medicine.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BenevolentAIunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    4-8 Maple Street, London, W1T 5HD
    Telephone
    Telephone
    +44 (0)2037 819 360
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.benevolent.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/benevolentai/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/benevolent_ai

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BenevolentAI Proposes Merger with Osaka Holdings for Delisting
    BenevolentAI Proposes Merger with Osaka Holdings for Delisting

    06 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250205177929/en

    BUSINESSWIRE
    06 Feb 2025
    Share Share
    BenevolentAI Announces Overhaul with Return to Original Mission
    BenevolentAI Announces Overhaul with Return to Original Mission

    11 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241210692976/en

    BUSINESSWIRE
    11 Dec 2024
    Share Share
    BenevolentAI pivots to 'TechBio' roots, causing more layoffs
    BenevolentAI pivots to 'TechBio' roots, causing more layoffs

    11 Dec 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/bavarian-nordic-plans-shut-down-san-diego-rd-site-laying-all-48-employees

    FIERCE BIOTECH
    11 Dec 2024
    Share Share
    BenevolentAI Appoints Kenneth Mulvany as Executive Chairman
    BenevolentAI Appoints Kenneth Mulvany as Executive Chairman

    17 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241016329782/en

    BUSINESSWIRE
    17 Oct 2024
    Share Share
    BenevolentAI To Present At BioTechX Europe 2024
    BenevolentAI To Present At BioTechX Europe 2024

    10 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241009679701/en

    BUSINESSWIRE
    10 Oct 2024
    Share Share
    BenevolentAI Interim Results for the Six Months Ended 30 June 2024
    BenevolentAI Interim Results for the Six Months Ended 30 June 2024

    19 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240918083461/en

    BUSINESSWIRE
    19 Sep 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search